Shared decision-making between the patient and their care team is indicated to decide whether to start, continue or discontinue GLP-1 therapy in the setting of a new diagnosis of NAION or in certain risk contexts, considering the individual patient characteristics and clinical scenario, the guidance article authors wrote
She explained that these kinds of incidents often don't happen during the drug's clinical trials because those studies include relatively small numbers of patients who are taking the drug for a limited time
N Engl J Med 1991;325:1593-6
References Frohman LA, Downs TR, Chomczynski P
It also examines methods for curcumin isolation, including pressurized fluid extraction, Soxhlet extraction, enzyme-assisted extraction, and microwave extraction